WST West Pharma Corp Gross Return on Sales

Corporate emblem and logo of West Pharma (WST)

West Pharmaceutical Services (WST) faces minimal risks due to its monopoly in injection packaging and stringent regulatory standards, which guarantee a stable cash flow. The aggregate gross margin visualizes these costs, where the 37.70 indicator determines the magnitude of the metric. Growth is driven by the mass production of sterile vials and organic expansion through the construction of plants in close partnership with drug developers.

West Pharmaceutical Services, Inc. (WST) - Gross Profitability from 07/04/2022 to 11/20/2026

Financial and market metric breakdowns for West Pharma (WST)

- stock value and consensus price forecast:
Core merchandise of West Pharmaceutical Services, Inc.

Gross margin measures production efficiency by determining the portion of revenue remaining after deducting direct costs of goods sold. For West Pharmaceutical Services (WST), this metric reflects the ability to monetize the critical importance of packaging systems for the global biologics and vaccines market. By analyzing the gross margin trajectory, an investor assesses the issuer's pricing power and the resilience of profits against inflation. A stable level of this metric confirms high competitiveness and the fundamental strength of the business.

Key competitors

Return on Gross Profit Intuitive|Gross Profitability Danaher Corp.|Gross Return on Sales BDX (Becton Dickinson & Co)|Return on Gross Profit STE (STERIS Corporation)|Gross Profit Ratio BAX|Masimo Corporation - Return on Gross Profit|Gross Profit Ratio STVN (Stevanato Group SpA)|TFX: Return on Gross Profit|Return on Sales by Gross Profit Merit Medical Corp MMSI|NVST: Gross Margin|ICUI - Return on Sales by Gross Profit|XRAY (Sirona Dental Systems) - Gross Margin|Gross Profit Margin LeMaitre Vascular Inc LMAT|Gross Profitability AtriCure Corp (ATRC)|Gross Margin STAAR Surgical Corp (STAA)|Gross Profitability niagenbioscience.com NAGE|ZimVie Inc. - Gross Profitability|ANGO - Gross Profitability|Return on Sales by Gross Profit Cerus Corp CERS|TKNO (Alpha Teknova Inc) - Return on Gross Profit|Monogram Technologies Inc - Gross Profit Rate|Return on Gross Profit STSS|InfuSystem Holdings, Inc. (INFU) - Return on Sales by Gross Profit|Gross Margin UTMD|KORU Medical - Gross Return on Sales|Nyxoah S.A - Return on Gross Profit|Gross Profit Rate MBOT|PDEX - Gross Profitability|ZTEK (Zentek) - Gross Return on Sales|ELUT (Elutia Inc) - Return on Gross Profit|MLSS - Return on Sales by Gross Profit|Gross Profitability NEXGEL, Inc.|RVP (Retractable Technologies) - Gross Profit Ratio|Gross Margin HBIO|FEMY: Gross Profitability Margin|Gross Profitability MeihuaMed MHUA|POAI - Return on Gross Profit|Callan JMB - Gross Margin|Atrion Corp - Gross Profit Ratio|NURO (neurometrix.com) - Return on Gross Profit